CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report...

103
CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses All statuses R2016 R2016 All statuses Report Parameters Abc 123 Site: Discrepancy status choice: Approval status choice: Verification status choice: Legend: How different values appear in the report The data contained in this report is current at the time of printing (time as shown above) All time stamps displayed in this report are in the timezone of the database server. Starting patient: Ending patient: Prompt Data value Data value with discrepancy

Transcript of CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report...

Page 1: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

CRF Report for Study E7694105Report run by Brian Saari at 05-MAR-2013 15:30:04

Abc 123

Abc 123

L0689282_2

All statuses

All statuses

R2016

R2016

All statuses

Report Parameters

Abc 123

Site:

Discrepancy status choice:

Approval status choice:

Verification status choice:

Legend: How different values appear in the report

The data contained in this report is current at the time of printing (time as shown above)All time stamps displayed in this report are in the timezone of the database server.

Starting patient:

Ending patient:

PromptData valueData value with discrepancy

Page 2: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 3: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 4: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 5: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 6: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

03.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 7: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 8: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 9: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 10: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 11: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

07.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 12: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 13: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 14: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

09.OS.1

OverFlow Section For Document Number R252109413

SHORTNESS OF BREATH UPON EXERTION DUE TO STRENUOUS ACTIVITY1

Page 15: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

09.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 16: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 17: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

10.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 18: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 19: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

11.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 20: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 21: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 22: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 23: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 24: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 25: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 26: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 27: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 28: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 29: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 30: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

20.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 31: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 32: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 33: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 34: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 35: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

24.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 36: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 37: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 38: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 39: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 40: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 41: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

29.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 42: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 43: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 44: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

31.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 45: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 46: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 47: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 48: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 49: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 50: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 51: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 52: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 53: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 54: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 55: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

39.1.U2.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 56: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 57: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

39.1.U3.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 58: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 59: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

39.1.U4.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 60: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 61: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

39.1.U5.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 62: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 63: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

39.1.U6.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Click here to navigate to discrepancy details for this CRF

Page 64: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 65: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 66: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

40.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 67: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 68: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 69: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 70: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 71: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

44.LINKS

Links to Discrepancy and Audit Sections

Click here to navigate to audit history for this CRF

Page 72: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 73: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses
Page 74: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Appendix: Audit and Discrepancy Information

Page 75: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 73Page

Page 76: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 74Page

Audit History Report

This section lists audited data that meets the parameters set when the report was run. It may not include all of the auditeddata in a particular CRF. Refer to the documentation for a complete description of the parameters that can affect this report.

Page 77: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 75Page

R246042213

Page_03

L0689282_2

R2016 Screening03

Ec Page number 3 Screening

IE

ExclusionCriteria Answer2

NAM

NO

26-FEB-2010 15:18:39

Amanda Lynn

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 78: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 76Page

R246043813

Page_07

L0689282_2

R2016 Screening07

CRF Header

DCI Blank Flag

DCI Blank Flag

1

1

N

Y

Y

N

22-SEP-2009 12:06:26

22-SEP-2009 12:07:08

Amanda Lynn

Amanda Lynn

Data Entry Error

Data Entry Error

0

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 79: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 77Page

R246043813

Page_07

L0689282_2

R2016 Screening07

Lb Page number 7 Screening

LB

Date

No (Specifysamples notdone, reason)/Co

RequisitionNumber 1: (1)

RequisitionNumber 2 (ifapplicable): (2)

RequisitionNumber 3 (ifapplicable): (3)

Were thescheduledlaboratorysamples ob

Were there anyclinicallysignificant la(1)

1

1

1

1

1

1

1

24-APR-2009

11468500150

YES

NO

22-SEP-2009 12:07:08

22-SEP-2009 12:07:08

22-SEP-2009 12:07:08

22-SEP-2009 12:07:08

22-SEP-2009 12:07:08

22-SEP-2009 12:07:08

22-SEP-2009 12:07:08

Amanda Lynn

Amanda Lynn

Amanda Lynn

Amanda Lynn

Amanda Lynn

Amanda Lynn

Amanda Lynn

Row Inserted

Row Inserted

Row Inserted

Row Inserted

Row Inserted

Row Inserted

Row Inserted

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 80: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 78Page

R252109413

Page_09

L0689282_2

R2016 Screening09

Mh Page number 9 Screening

MH1

Date of Onset

Date of Onset

Date ofResolution

Diagnosis/Procedure

Diagnosis/Procedure

Diagnosis/Procedure

Diagnosis/Procedure

Ongoing

Ongoing

Sequence Number

Sequence Number

Sequence Number

Sequence Number

3

3

3

3

3

3

3

3

3

3

3

3

4

00-00-2006

SHORTNESS OF BREATH DUETO STRENOUS ACTIVITY

SHORTNESS OF BREATH DUETO STRENUOUS ACTIVITY

SHORTNESS OF BREATH UPONEXERTION DUE TO STRENOUSACTIVITY

CHECKED

03

04

05

<Row Deleted>

<Row Deleted>

SHORTNESS OF BREATH DUETO STRENUOUS ACTIVITY

<Row Deleted>

SHORTNESS OF BREATH UPONEXERTION DUE TOSTRENUOUS ACTIVITY

<Row Deleted>

<Row Deleted>

03

04

10-MAR-2010 10:02:37

24-MAR-2010 15:32:39

24-MAR-2010 15:32:39

24-FEB-2010 14:14:36

10-MAR-2010 10:02:37

24-MAR-2010 15:32:39

24-FEB-2010 14:14:36

10-MAR-2010 10:02:37

24-MAR-2010 15:32:39

10-MAR-2010 10:02:37

24-MAR-2010 15:32:39

10-MAR-2010 10:02:37

10-MAR-2010 10:02:37

Amanda Lynn

Krysia Magnuson

Krysia Magnuson

Krysia Magnuson

Amanda Lynn

Krysia Magnuson

Krysia Magnuson

Amanda Lynn

Krysia Magnuson

Amanda Lynn

Krysia Magnuson

Amanda Lynn

Amanda Lynn

Strenous toStrenuous.

Strenous toStrenuous.

Data Entry Error

Data Entry Error

Data Entry Error

ODM/SEC

Data Entry Error

Data Entry Error

ODM/SEC

Data Entry Error

Data Entry Error

Data Entry Error

Data Entry Error

Data Entry Error

Data Entry Error

2

5->4;4->3

5->4;4->3

5->4;4->3

5->4;4->3

5->4;4->3

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 81: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 79Page

R246045113

Page_10

L0689282_2

R2016 Screening10

Smoking History Page number 10 Screening

DRUGSCR

Comments (NRT)(4)

If yes, how many(other attemptsto quit (6)

1

1

LOENGE 2006, 2007, 2008

SEVERAL

LOZENGE 2006, 2007, 2008

1

08-MAR-2010 14:22:16

22-SEP-2009 12:07:59

Krysia Magnuson

Amanda Lynn

Loenge to Lozenge.KAY 08Mar2010.

ODM/SEC

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 82: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 80Page

R246046613

Page_11

L0689282_2

R2016 Screening11

Oral Health Exam Page number 11 Screening

EX1

Findings*

3

NE

NO

11-JUN-2009 16:01:03

Amanda Lynn

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 83: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 81Page

R263844213

Page_20

L0689282_2

R2016 Ip, Week 620

Status Review Page number 20 Ip, Week 6

CHKYN

If Subject wasnot compliant,approximat (5)

If Subject wasnot compliant,approximat (5)

Was Subjectcompliant (4)

Was Subjectcompliant (4)

1

1

1

1

40

NO

YES

UNK

YES

NO

23-OCT-2009 15:01:40

15-DEC-2009 10:12:12

23-OCT-2009 15:01:40

15-DEC-2009 10:12:12

Amanda Lynn

Amanda Lynn

Amanda Lynn

Amanda Lynn

Data Entry Error

Data Entry Error

Data Entry Error

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 84: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 82Page

R263848113

Page_24

L0689282_2

R2016 Ip, Week 1024

Status Review Page number 24 Ip, Week 10

CHKYN

If Subject wasnot compliant,approximat (5)

If Subject wasnot compliant,approximat (5)

Was Subjectcompliant (4)

Was Subjectcompliant (4)

1

1

1

1

3

NO

YES

UNK

YES

NO

23-OCT-2009 15:02:21

15-DEC-2009 10:14:53

23-OCT-2009 15:02:21

15-DEC-2009 10:14:53

Amanda Lynn

Amanda Lynn

Amanda Lynn

Amanda Lynn

Data Entry Error

Data Entry Error

Data Entry Error

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 85: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 83Page

R270750513

Page_29

L0689282_2

R2016 Ip, Week 1629

Pe Page number 29 Ip, Week 16

MH1

Does the subjecthave anyabnormal findi

Does the subjecthave anyabnormal findi

1

1

NO

YES

YES

NO

22-SEP-2009 12:12:21

22-SEP-2009 12:12:27

Amanda Lynn

Amanda Lynn

Pass1

Pass1

2

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 86: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 84Page

R270751113

Page_31

L0689282_2

R2016 Ip, Week 1631

Status Review Page number 31 Ip, Week 16

CHKYN

If Subject wasnot compliant,approximat (5)1

56

49

23-OCT-2009 15:03:43

Amanda Lynn

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 87: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 85Page

R246055713

Page_39

L0689282_2

R2016 Pcm.2

Pcm Page number 39 Pcm.2

CM1

ATC1 Code

ATC1 Text

ATC2 Code

ATC2 Text

ATC3 Code

ATC3 Text

ATC4 Code

ATC4 Text

Indication

Preferred Term

Preferred TermCode

1

1

1

1

1

1

1

1

1

1

1

PREVATATIVE SUPPLEMENT

A

ALIMENTARY TRACT ANDMETABOLISM, A

A11

VITAMINS, A11

A11A

MULTIVITAMINS,COMBINATIONS, A11A

A11AB

MULTIVITAMINS, OTHERCOMBINATIONS, A11AB

PREVENTATIVE SUPPLEMENT

MULTIVITAMINS

00116001001

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

09-APR-2010 15:04:21

26-APR-2010 10:36:00

26-APR-2010 10:36:00

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Joanne Mccaigue

Carol Kraucyk

Carol Kraucyk

Obvious spellingcorrection. JLM09Apr2010

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

ODM/SEC

Class. Change

Class. Change

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 88: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 86Page

R246056513

Page_39

L0689282_2

R2016 Pcm.3

Pcm Page number 39 Pcm.3

CM1

ATC1 Code

ATC1 Text

ATC2 Code

ATC2 Text

ATC3 Code

ATC3 Text

Drug ModifiedReported Term

Drug name

Preferred Term

Preferred TermCode

1

1

1

1

1

1

1

1

1

1

EXTREME TRIM

EXTREME TRIM

V

VARIOUS, V

V07

ALL OTHER NON-THERAPEUTIC PRODUCTS,V07

V07A

ALL OTHER NON-THERAPEUTIC PRODUCTS,V07A

XTREME TRIM

XTREME TRIM

ALL OTHER NON-THERAPEUTIC PRODUCTS

90047501001

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

26-APR-2010 10:36:00

20-APR-2010 11:29:16

09-APR-2010 15:04:47

26-APR-2010 10:36:00

26-APR-2010 10:36:00

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Carol Kraucyk

Joanne Mccaigue

Carol Kraucyk

Carol Kraucyk

Obvious spellingcorrection. JLM09Apr2010

Data Change

Data Change

Data Change

Data Change

Data Change

Data Change

Data Change

ODM/SEC

Data Change

Data Change

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 89: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 87Page

R246058413

Page_39

L0689282_2

R2016 Pcm.4

Pcm Page number 39 Pcm.4

CM1

Ongoing

Stop Date

1

1

CHECKED

00-JUN-2009

20-OCT-2009 10:32:57

20-OCT-2009 10:32:57

Amanda Lynn

Amanda Lynn

Data Entry Error

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 90: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 88Page

R246060513

Page_39

L0689282_2

R2016 Pcm.5

CRF Header

DCI Blank Flag

1

N

Y

12-APR-2010 12:32:13

Amanda Lynn

Data Entry Error

0

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 91: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 89Page

R246063013

Page_39

L0689282_2

R2016 Pcm.6

Pcm Page number 39 Pcm.6

CM1

ATC1 Code

ATC1 Text

ATC2 Code

ATC2 Text

ATC3 Code

ATC3 Text

ATC4 Code

ATC4 Text

Indication

1

1

1

1

1

1

1

1

1

C

CARDIOVASCULAR SYSTEM, C

C01

CARDIAC THERAPY, C01

C01E

OTHER CARDIACPREPARATIONS, C01E

C01EB

OTHER CARDIACPREPARATIONS, C01EB

OSTEOARTHRITIS

M

MUSCULO-SKELETAL SYSTEM,M

M01

ANTIINFLAMMATORY ANDANTIRHEUMATIC PRODUCTS,M01

M01A

ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS, M01A

M01AE

PROPIONIC ACIDDERIVATIVES, M01AE

PAIN RELATED TOOSTEOARTHRITIS

27-APR-2010 12:10:38

27-APR-2010 12:10:38

27-APR-2010 12:10:38

27-APR-2010 12:10:38

27-APR-2010 12:10:38

27-APR-2010 12:10:38

27-APR-2010 12:10:38

27-APR-2010 12:10:38

22-OCT-2009 14:23:53

Joanne Mccaigue

Joanne Mccaigue

Joanne Mccaigue

Joanne Mccaigue

Joanne Mccaigue

Joanne Mccaigue

Joanne Mccaigue

Joanne Mccaigue

Amanda Lynn

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

Class. Change

Data Entry Error

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 92: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 90Page

R248768313

Page_40

L0689282_2

R2016 Ae40

Ae Page number 40 Ae

AE1

Adverse Event

1

BURNING SENSATION ONGUMSGINGIVAL DISCOMFORT

13-AUG-2009 13:53:50

Amanda Lynn

Pass1

1

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 93: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 91Page

R283616213

Page_44

L0689282_2

R2016 Additional Pe44

CRF Header

DCI Blank Flag

1

N

Y

08-DEC-2009 15:16:28

Amanda Lynn

Data Entry Error

0

Document #:

PatientSite

Visit

Visit Date

CRFCRF Page

SectionSection Date

Qualifying Prompt Qualifying Value Section Visit

Group # Group Name

FieldRow

Changed From

Changed ToImpact onresequence

OnBy

Reason

Comment

Page 94: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 92Page

R246042213

L0689282_2 R201674115011

SCREENING

EC 3PAGE_03

Exclusion Criteria Answer 2

CURRENT

Data value changed. Disc no longer applicable.

MANUAL

Resolved-Response Edited

NO

For consistency with other subject's data, please update response to 'No' rather than 'NAMale'.

Discrepancy Detail ReportDocument #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 95: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 93Page

R246043813

L0689282_2 R20161737297413

SCREENING

UPREG 7PAGE_07

CURRENT

Data value changed. Disc no longer applicable.

MANUAL HEADER

Resolved-Response Edited

Please complete

Document #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 96: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 94Page

R246043813

L0689282_2 R20161737299713

SCREENING

DRGSCR 7PAGE_07

CURRENT

Data value changed. Disc no longer applicable.

MANUAL HEADER

Resolved-Response Edited

Please complete

Document #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 97: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 95Page

R246045113

L0689282_2

L0689282_2

R2016

R2016

1737302413

1737302313

SCREENING

SCREENING

SMOKING HISTORY

SMOKING HISTORY

10

10

PAGE_10

PAGE_10

Comments (other attemps)

If yes, how many (other attempts to quit

1

1

CURRENT

CURRENT

No Action Required

Data value changed. Disc no longer applicable.

MANUAL

MANUAL

Resolved-Response Edited

Resolved-Response Edited

COLD TURKEY THROUGH 1994 -2000

1

Please update comment text (per DCF 7137302413) to clarify that the subject successfullyquit for the years listed. (e.g. "Subject successfully quit from 1994-2000 using the coldturkey method".

Please update after source has been clarified

I can't that comment is not on our source so I cannot write that. Please leave as is.

Per progress note on 24Apr2009, subject quit for 6 yrs cold turkey. # of times is = to 1

Document #:

Discrepancy ID:

Discrepancy ID:

Visit:

Visit:

CRF:

CRF:

Field:

Field:

Value Text:

Value Text:

Type:

Type:

Review Status:

Review Status:

Discrepancy:

Discrepancy:

Internal Comment:

Internal Comment:

Resolution Type:

Resolution Type:

Resolution Text:

Resolution Text:

Status:

Status:

Site:

Site:

Visit Date:

Visit Date:

Section:

Section:

Patient:

Patient:

Qualifying Value:

Qualifying Value:

Row:

Row:

Page 98: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 96Page

R252109413

L0689282_2 R201679764011

SCREENING

MH 9PAGE_09

Diagnosis/Procedure 3

CURRENT

Data value changed. Disc no longer applicable.

MANUAL

Resolved-Response Edited

SHORTNESS OF BREATH UPON EXERTION DUE TO STRENUOUS ACTIVITY

Please remove MH #3 or #4 as they appear to be the same diagnosis.

Document #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 99: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 97Page

R263844213

L0689282_2 R20161790986813

IP, WEEK 6

STATUS REVIEW 20PAGE_20

Was Subject compliant 1

CURRENT

Data value changed. Disc no longer applicable.

MANUAL

Resolved-Response Edited

NO

Per return questionnaire subject smoked the week prior to wk 6 clinic visit. Wk 6 diaryhowever states that no cigarettes were smoked. Please clarify.

Document #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 100: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 98Page

R263848113

L0689282_2 R20161790987113

IP, WEEK 10

STATUS REVIEW 24PAGE_24

Was Subject compliant 1

CURRENT

Data value changed. Disc no longer applicable.

MANUAL

Resolved-Response Edited

NO

Per return questionnaire, subject smoked cigarettes and was given instructions regardingquiting. Please verify number of cigarettes and compliance. Diary and questionnaire donot match.

Document #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 101: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 99Page

R246058413

L0689282_2 R20161737330713

PCM.4

PCM 39PAGE_39

Stop Date 1

CURRENT

Data value changed. Disc no longer applicable.

MANUAL

Resolved-Response Edited

200906

Please review if medication was stopped on 00-Jun-2009

Document #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 102: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 100Page

R246063013

L0689282_2 R20161737330913

PCM.6

PCM 39PAGE_39

Indication 1

CURRENT

Data value changed. Disc no longer applicable.

MANUAL

Resolved-Response Edited

PAIN RELATED TO OSTEOARTHRITIS

Please review if ibuprofen was given for oesteoarthritis or for pain related tooesteoarthritis

Document #:

Discrepancy ID:

Visit:

CRF:

Field:

Value Text:

Type:

Review Status:

Discrepancy:

Internal Comment:

Resolution Type:

Resolution Text:

Status:

Site:

Visit Date:

Section:

Patient:

Qualifying Value:

Row:

Page 103: CRF Report for Study E7694105 - accessdata.fda.gov ap… · CRF Report for Study E7694105 Report run by Brian Saari at 05-MAR-2013 15:30:04 Abc 123 Abc 123 L0689282_2 All statuses

Report run by Brian Saari at 05-MAR-2013 15:30:08 101Page

Deleted CRFs Report